SCHEMBL7959804

SCHEMBL7959804

O=C(O)c1ccc(CC2=C(c3nc(-c4ccccc4)c(-c4ccccc4)o3)C3CCC2C3)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.48
PTGIR P43119 5/20 0.48
PTGER1 P34995 1/20 0.48
NR4A2 P43354 9/20 0.42
RXRA P19793 2/20 0.42
RXRB P28702 2/20 0.42
RXRG P48443 2/20 0.42
NR4A1 P22736 2/20 0.39
NR4A3 Q92570 2/20 0.39
PTGER3 P43115 1/20 0.38
FABP4 P15090 2/20 0.37
FABP3 P05413 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ABCC4 O15439 1/20 0.37
C5 P01031 1/20 0.37
LMNA P02545 1/20 0.37
CHRM2 P08172 1/20 0.37
CYP3A4 P08684 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD2 P14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960373 0.89 PTGIR (0.59) PTGER4PTGIRPTGER1NR4A2RXRA
SCHEMBL7949757 0.84 PTGIR (0.51) PTGER4PTGIRPTGER1NR4A2RXRA
SCHEMBL7949669 0.81 PTGIR (0.49) PTGER4PTGIRPTGER1NR4A2RXRA
SCHEMBL7490977 0.80 FABP4 (0.58) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7493731 0.77 PTGIR (0.44) PTGER4PTGIRPTGER1RXRARXRB
SCHEMBL7957475 0.75 PTGIR (0.43) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7959978 0.74 PTGER4 (0.71) PTGER4PTGIRPTGER1NR4A2RXRA
SCHEMBL11527476 0.73 NPC1 (0.61) NR4A2RXRARXRBRXRGNR4A1
SCHEMBL7960451 0.73 PTGER4 (0.81) PTGER4PTGIRPTGER1NR4A2RXRA
SCHEMBL7957721 0.73 PTGER4 (0.81) PTGER4PTGIRPTGER1NR4A2RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed